Alvotech (ALVO) Tax Provisions (2022 - 2024)

Alvotech (ALVO) reported Tax Provisions of -$14.3 million for Q4 2024, down 114.4% on a YoY basis from $99.3 million in Q1 2024, and down 114.4% quarter-over-quarter from $99.3 million in Q4 2023.

Alvotech (ALVO) Tax Provisions (2022 - 2024) Analysis & Trends

Alvotech has reported Tax Provisions for 3 years, with the latest figure at -$14.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 67.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 157.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.40 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -3.57 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 48.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 30.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.60 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -9.44 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 37.99 Mn
10 Alvotech 12.16 Mn -160.20 Mn -22.39 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -14.30 Mn
Dec 31, 2023 99.32 Mn
Dec 31, 2022 38.07 Mn